Related Experiment Video
Updated: Oct 3, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA)
M Bassetti1, A Di Biagio, G Cenderello
1Department of Infectious Disease, University of Genoa School of Medicine, San Martino Hospital, Genoa, Italy. mattba@tin.it
Abstract:
Prosthetic joint infection is an infrequent but serious complication of total joint arthroplasty. Complete removal of all foreign material is essential, however when prosthesis removal is not possible or contraindicated, suppressive antibiotic therapy with retention of the functioning hip arthroplasty may be considered. Linezolid, the first approved oxazolidinone, appears to be a promising new agent for the treatment of serious Gram-positive infections. We report two cases of Methicillin-resistant Staphylococcus aureus (MRSA) prosthetic hip infections successfully treated with a long course of linezolid. This observation suggest that linezolid is a promising drug for the treatment of prosthetic joint infections due to MRSA or other Gram-positive pathogens, particularly when other therapeutic approaches are not feasible or a long-term antibiotic therapy is required.
Insights
Linezolid offers a promising treatment for prosthetic joint infections caused by Methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic may be effective for long-term suppressive therapy when prosthesis removal is not an option.
Area of Science:
- Infectious Diseases
- Orthopedic Surgery
- Pharmacology
Background:
- Prosthetic joint infection is a severe complication of total joint arthroplasty.
- Complete removal of infected material is crucial, but not always feasible.
- Suppressing infection with antibiotics may be an alternative to prosthesis removal.
Observation:
- Two cases of hip joint infections caused by Methicillin-resistant Staphylococcus aureus (MRSA) were reported.
- Patients had prosthetic hip joint infections.
- These infections were treated with a prolonged course of linezolid.
Findings:
- Both cases of MRSA prosthetic hip infections were successfully treated with linezolid.
- Linezolid demonstrated efficacy in managing these difficult-to-treat infections.
- Long-term suppressive antibiotic therapy with linezolid was effective.
Implications:
- Linezolid shows promise for treating prosthetic joint infections, especially those caused by MRSA.
- It is a potential therapeutic option when other treatments are not feasible.
- This suggests linezolid's utility in long-term antibiotic management of Gram-positive prosthetic joint infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Hand hygiene
Hand washing...